Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01383265 · ClinicalTrials.gov registry record · NA
Combined Chromoendoscopy and Water Method for Screening Colonoscopy
A NA study, sponsored by VA Northern California Health Care System.
- Completed
- Registry status
- NA
- Development phase
- 1,177
- Enrollment target
NCT01383265: Completed NA study, sponsored by VA Northern California Health Care System.
NCT01383265 is a NA study that has completed, run by VA Northern California Health Care System. The registered enrollment target is 1,177 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (16% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01383265, a NA study, has completed, sponsored by VA Northern California Health Care System.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,177 participants
- Enrollment target
Study Summary
In a RCT in screening colonoscopy subjects, we will determine if chromoendoscopy using a dilute solution of Indigocarmine (IC) delivered by the water method (study method) will improve adenoma detection rate compared with the water method with plain water alone (control method).
Interventions
- PROCEDURE Water method and chromoendoscopy
- PROCEDURE Water method
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,177 participants |
| Start Date | 2010-03 |
| Est. Completion | 2013-06 |
| Phase | NA |
What the finished NCT01383265 record still lists
NCT01383265 is an interventional study that assigns participants to a tested intervention. Its 1,177 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (16% lower).
The record links to 0 conditions, and to 2 interventions - of which Water method and chromoendoscopy is the first listed.
NCT01383265 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01383265 about?
NCT01383265 is a clinical study titled "Combined Chromoendoscopy and Water Method for Screening Colonoscopy". In a RCT in screening colonoscopy subjects, we will determine if chromoendoscopy using a dilute solution of Indigocarmine (IC) delivered by the water method (study method) will improve adenoma detection rate compared with the water method with plain water alone (control method).
What is the current status of trial NCT01383265?
This trial is currently completed. It is a NA study. The enrollment target is 1,177 participants. The study started on 2010-03. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01383265?
The interventions under investigation include: Water method and chromoendoscopy (PROCEDURE), Water method (PROCEDURE).
Who is sponsoring clinical trial NCT01383265?
This trial is sponsored by VA Northern California Health Care System, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01383265's enrollment target sits among peer trials
1,177 90th of 2000 higher than 1,911 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05688436 · 1,178 participants
A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies
- NCT06931275 · 1,178 participants · NA
Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes
- NCT06133322 · 1,176 participants · NA
Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSED)
- NCT04275557 · 1,174 participants
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia